This inventor holds 3 USPTO granted patents and 2 published patent applications. Top assignee: Dr. Reddy's Laboratories, Incorporated. Active years: 2010-2016.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:

Years Active: 2010-2016
Title: Raghupathi Reddy Anumula: Innovator in Pharmaceutical Chemistry
Introduction
Raghupathi Reddy Anumula is a notable inventor based in Hyderabad, Telangana, India. He has made significant contributions to the field of pharmaceutical chemistry, particularly in the development of processes for preparing important medications. With a total of 3 patents to his name, Anumula has demonstrated a commitment to innovation in drug formulation.
Latest Patents
Anumula's latest patents include the preparation of Ticagrelor, which involves processes for creating Ticagrelor and its intermediates. These processes are essential for the pharmaceutical industry, as they provide methods for producing this important medication. Additionally, he has developed a process for the preparation of Celecoxib, which includes reacting specific chemical compounds in a solvent medium. His work also encompasses the purification of Celecoxib using aromatic hydrocarbon solvents, showcasing his expertise in chemical processes.
Career Highlights
Raghupathi Reddy Anumula is associated with Dr. Reddy's Laboratories, Incorporated, a leading pharmaceutical company known for its innovative drug development. His role in the company has allowed him to contribute to various projects that aim to improve healthcare outcomes through effective medication.
Collaborations
Anumula has worked alongside talented colleagues such as Goverdhan Gilla and Yakambram Bojja. Their collaborative efforts have further enhanced the research and development initiatives at Dr. Reddy's Laboratories.
Conclusion
Raghupathi Reddy Anumula is a distinguished inventor whose work in pharmaceutical chemistry has led to significant advancements in drug preparation processes. His contributions continue to impact the industry positively, making him a valuable asset to the field.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile